Linn et al. found that OCT-3/4 was upregulated in drug-resistant cell lines by microarray analysis, RT-PCR, sequencing, and Western blotting [57], suggesting that upregulation of OCT-3/4 plays an essential role in regulating growth and survival of drug resistant cancer cells such as prostate cancer cells. Here, POU5F1 is linked to prostate carcinoma.